Effects of Insulin on Proliferation, Apoptosis, and Ferroptosis in Primordial Germ Cells via PI3K-AKT-mTOR Signaling Pathway

394
0
2023-10-25 17:00
MDPI
PTLv2
Followers:3Columns:927

1. Introduction

Primordial germ cells (PGCs) are the progenitor cells of all animal germ cells, which eventually differentiate into sperm and eggs and are important carriers for the stable transmission of genetic information between generations [1,2,3] and have now become the tool cells to solve the bottleneck of avian biotechnology. Numerous experiments have demonstrated that exogenous PGCs (germinal crescent, blood, and gonads) from different time periods can colonize the gonads of homozygous recipient chickens and eventually develop into germline chimeras with the ability to spread germline [4,5,6]. In addition to the ability to proliferate in vitro, chicken primary germ cells can also be stored at low temperatures and genetically modified [7,8,9,10,11]. The results from these studies are not only a breakthrough for the establishment of avian genetic transformation technology but also a great contribution to the conservation and restoration of poultry germplasm resources. However, the number of PGCs isolated from embryos is far from sufficient to meet the actual needs due to the unclear genetic and molecular regulation mechanism of the growth and proliferation of chicken PGCs, which greatly limits the application of this technical system [12]. Studies have shown that the combined action of multiple growth factors and stromal cells alters the developmental program of PGCs by blocking their differentiation to mature germ cells while stimulating their proliferation in large numbers [13,14,15,16]. Pesce et al. reported that stem cell factor (SCF) and the leukemia inhibitory factor (LIF) promote the survival and proliferation of PGCs via the inhibition of apoptosis [17]. The addition of LIF, SCF, and basic fibroblast growth factor (bFGF) inhibits the apoptosis of 8.5 dpc PGCs cultured on feeder cells in vitro, promotes their proliferation and cell colony production, and maintains a pluripotent state [18,19,20,21]. Activin A also plays an important role in the PGC culture in vitro [22].

Insulin, a member of the peptide hormone family, has been reported to promote cell proliferation. Insulin enhances thyroid cell proliferation and tumor cell migration [23]. Insulin activates the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB, also known as Akt) pathway and mitogen-activated protein kinase (MAPK) signaling pathway to promote cell proliferation and apoptosis resistance [24]. In addition, insulin elevates cell viability. Studies have shown that mice administered with insulin exhibit higher follicle survival, lumen formation, and more mature oocyte production [25]. Insulin inhibits apoptosis after cleavage and the dissociation of cysteine aspartate and activates the insulin-like growth factor (IGF) receptor and PI3K/AKT cascade to promote cell survival [26]. Furthermore, insulin does exhibit various effects on cell behavior. Studies have shown that moderate amounts of insulin promote the proliferation of human arterial smooth muscle cells, while high concentrations of insulin reduce the efficiency of proliferation [27].

Lacking enough evidence from the literature, it is unclear whether the cellular activity response of PGCs undergoing different insulin doses may differ. Therefore, the objective of this study was to investigate the effects of insulin at different doses on the proliferation and cellular activity of PGCs.

2. Materials and Methods

2.1. Ethics Approval

All animal experiments were approved by the Institutional Animal Care and Use Committee of Yangzhou University (approval number: 132-2022). All procedures were strictly performed in accordance with the Regulations for the Administration of Affairs Concerning Experimental Animals (Yangzhou University, Yangzhou, China, 2012) and the Standards for the Administration of Experimental Practices (Yangzhou, China, 2008).

2.2. Isolation, Culture, and Identification of PGCs

The fertilized breeding eggs of Rugao yellow chickens were obtained from the Poultry Live Preservation Gene Bank, Institute of Poultry Research, Chinese Academy of Agricultural Sciences (Yangzhou, China). Fresh 4.5 d fertilized embryonic eggs were taken and washed in water with Neosporin disinfectant and 75% alcohol. Under aseptic conditions, the egg shell was gently tapped with the blunt end of forceps, and the tipped part of the forceps was used to peel the cracked egg shell. Then, the embryo was gently picked out, and the embryo was cleaned with PBS two times. Then, the internal organs were removed under a body microscope, and the germinal crests of the embryos were taken from the anterior 1/3 dorsal spine of the hindgut and put into 1.5 mL centrifugation tubes, which were then centrifugated at 370× g for 6 min, and the supernatant was removed. The supernatant was washed again with PBS, added to 100 μL trypsin (0.25%) digestion, ground for 1 min, added 200 µL PGCs complete medium to terminate the digestion, centrifuged at 370× g for 3 min, discarded the supernatant, resuspended to a 48-well plate, and cultured at 37 °C, 5% CO2 incubator. Mulberry-like PGC cells could be observed under the inverted microscope. In our experiment, we had a nutritional deficiency of insulin. PGCs were seeded in 24-well plates and cultured in complete media without insulin B27 was replaced by B27 minus insulin (Gibco-A1895601, Shanghai, China) supplemented with gradient concentrations of insulin at 0, 5, 10, 20, 50, and 100 μg/mL, for 72 h.

Cells were collected in well plates, rinsed twice with phosphate-buffered saline (PBS), then drop the cells onto the slide, fixed with 4% paraformaldehyde for 30 min, rinsed three times with PBS; 0.1% Triton permeable membrane was treated for 15 min, rinsed three times with PBS, PBS with 10% FBS added was closed for 2 h against light and then a primary antibody SSEA-1 (Abcam-ab16285, 1:400, Shanghai, China) was added dropwise and incubated at 37 °C for 2 h and then overnight at 4 °C; PBS washed with a primary antibody, a secondary antibody (BOSTER-BA1101, 1:400, Wuhan, China) was added dropwise, incubated at 37 °C. After incubation for 2 h at 37 °C, and then the secondary antibody was washed with PBS, stained with 5 ng/μL of Hoechst (Ribobio-U1202, Guangzhou, China) for 15 min, and washed the stain, buffer glycerol (50% glycerol, 50% PBS) to seal the film after dropping the oil. The fluorescence was observed under the microscope.

2.3. PGCs Proliferative Capacity Test

The proliferative capacity was detected using CCK-8 kit (A311-01, Vazyme, Nanjing, China) according to the manufacturer’s instruction. Briefly, 100 μL cell solution (1 × 106/mL) of PGCs at logarithmic growth stage was seeded in 96-well plates in triplicate. Then, 10 μL of CCK-8 solution was added, followed by the incubation at 37 °C and 5% CO2 for 2 h. The absorbance at 450 nm was read using microplate reader (TECAN SPARK, Shanghai, China).

After the Edu-labeling (C10310-1, Ribobio, Guangzhou, China), fixation, and permeabilization, PGCs were incubated with Click reaction solution for 30 min at room temperature in dark and then stained with Hoechst33342 for 10 min at room temperature in dark. Fluorescence was observed under fluorescence microscope (LEICA DMi8, Beijing, China).

2.4. Quantitative PCR

Invitrogen TRIzol (ThermoFisher-15596026, Shanghai, China) and FastKing gDNA Dispelling RT SuperMix (TIANGEN-KR118, Beijing, China) were used for RNA extraction and cDNA synthesis. 1 μg RNA was used for cDNA synthesis. The kit method extracted RNA, and reverse transcribed cDNA was stored frozen at −20 °C. Primers for ferroptosis, apoptosis, PI3K-Akt-mTOR, and cell cycle-related genes were designed according to GenBank using BLAST software in NCBI , and ACTIN was used as an internal reference gene. The qRT-PCR technique was used to detect the mRNA expression levels of each gene in PGCs after the treatment of insulin at different concentrations. Moreover, 10 μL qRT-PCR reaction system consists of 5 μL 2× Universal SYBR Green Fast qPCR Mix, 0.4 μL upstream primer (10 μM), 0.4 μL downstream primer (10 μM), 2 μL cDNA, ddH2O to 10 μL. Reaction procedure: 95 °C for 3 min; 95 °C for 5 s; and 60 °C for 30 s with 40 cycles in total. Three biological replicates were set for the culture of PGCs, and three technical replicates were set for each sample. Expression levels were quantified using the 2−ΔΔCT method.

2.5. Western Blot Test

PGCs were collected and lysed using Radio-Immunoprecipitation Assay (RIPA) lysis solution (Beyotime-P0013B, Shanghai, China). Extracted total proteins were separated and transferred to PVDF membrane (Beyotime-FFP39, Shanghai, China) via electrophoresis. Blots were blocked using 5% skimmed milk at room temperature for 2 h, followed by the incubation of primary antibody solution (PI3K (BIOSS-bsm-33219M, Beijing, China), p-PI3K (BIOSS-bs-6417R, Beijing, China), AKT (Affinity-AF6261, Liyang, China), p-AKT (BIOSS-bs-0876R, Beijing, China), GAPDH (Proteintech-10494-1-AP, Wuhan, China)) at 4 °C overnight. After 3 washes with TBST, the blots were incubated with secondary antibody solution (Goat Anti-Mouse IgG (CWBIO-CW0102, Taizhou, China), Goat Anti-Rabbit IgG (CWBIO-CW0103, Taizhou, China) at room temperature for 2 h. The blots were washed 3 times with TBST (Solarbio-T1082, Beijing, China) and subjected to imaging using chemiluminescent substrate.

2.6. PGCs Ferrous Ion Detection

The cytosolic ferrous colorimetric assay kit (E-BC-K881-M, Elabscience, Wuhan, China) was used to detect ferrous ions according to the manufacturer’s instructions. Briefly, 1 × 106/mL PGCs were seeded in 96-well plates and incubated with staining solution at 37 °C for 10 min. The absorbance at 593 nm was read by a microplate reader (TECAN SPARK, Shanghai, China).

2.7. PGCs Oxidation Levels Detection

PGCs were inoculated in 24-well plates at 1 × 105/mL. Different concentrations of insulin were added and incubated for 72 h. The cell precipitates were collected.

The Malondialdehyde (MDA) content was detected according to MDA kit (KGT004-1, KeyGEN, Nanjing, China). The sample was resuspended in PBS and lysed via low-temperature ultrasonication, and the protein concentration was determined using bicinchoninic acid (BCA) method, and the MDA working solution was configured. Then, 100 µL of sample was taken, mixed with 1 mL of working solution, heated at 95 °C for 1 h, cooled to room temperature, and centrifuged at 6000× g for 10 min, and the supernatant was taken. Next, 200 µL of sample was added into a 96-well plate, and the absorbance at 532 nm was detected using enzyme marker (TECAN SPARK, Shanghai, China).

The GSH/GSSG content was detected according to GSH and GSSG kit (S0053, Beyotime, Shanghai, China). PGCs in logarithmic phase were inoculated into 6-well plates at 3 × 105 cells/well, and protein remover S solution was added at 3 times the volume of cell sedimentation when the cell fusion was about 50%. Cells were rapidly frozen and thawed 3 times and centrifuged at 12,000× g for 10 min, and the supernatant was used for GSH assay. The absorbance at 412 nm was detected using enzyme marker (TECAN SPARK, Shanghai, China), and the GSH content was calculated from the standard curve.

2.8. PGCs Apoptosis Detection

PGCs were inoculated in 6-well plates at a density of 1 × 106/mL (1 mL per well) and incubated with different concentrations of insulin for 72 h. The cell sediment was collected. The cells were washed twice with PBS and double-stained with AnnexinV/PI (YEASEN-40302ES, Shanghai, China), incubated for 5 min at room temperature with no light, and then detected on the machine.

2.9. Statistical Analysis

Statistical analyses of data were performed using one-way ANOVA of SPSS 22.0 and GraphPad Prism 8 software (GraphPad Software Inc., San Diego, CA, USA) and presented as the mean ± SEM. p < 0.05 was considered to represent a statistically significant difference.

3. Results

3.1. Insulin Regulates PGC Proliferation in a Dose-Dependent Manner

SSEA-1 was specifically expressed on chicken PGCs, and via immunofluorescence, we confirmed that the isolated cells were PGCs (Figure 1A). Studies have shown that insulin is an essential factor for the cell culture. B-27 is an important factor in culturing PGCs in our laboratory, which contain insulin, and the dose of insulin is not yet known. To investigate the effect of insulin on the culture of PGCs, the insulin was removed from the culture medium, which led to abnormal cell morphology of PGCs (Figure 1B,C): The proliferation of PGCs was decreased with an irregular shape of cells after removal of insulin, while it was rescued after the addition of insulin back to the culture medium. These results indicate that insulin is indispensable in the process of culturing PGCs. In order to screen the optimal dosage of insulin for maintaining PGCs, we cultured PGCs in a medium containing different concentrations of insulin and detected the cellular activity of PGCs.

Figure 1. Morphological observation and identification of PGCs. (A) Identification of isolated PGCs. (B) Cell morphology of PGCs cultured with B-27 (minus insulin). (C) Cell morphology of PGCs cultured with B-27.

PGCs exposed in a low concentration range (10 μg/mL) exhibited a good state, while those in higher concentrations of insulin presented obvious clumps and cell fragments (Figure 2A). Insulin significantly promoted the proliferation of PGCs in the low concentration range (10 μg/mL) (p < 0.05). Interestingly, insulin at higher concentrations had less effect on the proliferative rate of PGCs (p < 0.05) (Figure 2B,C). These results tentatively imply that insulin regulates the proliferative capacity of PGCs dose dependently.

Figure 2. Insulin mediates PGC growth in a dose-dependent way. (A) Cell morphology of PGCs under insulin treatment at different concentrations. (B,C) Cell proliferation rate of PGCs using CCK-8 kit (B) and EDU kit (C). (D) EDU staining of PGCs. a,b,c,d,e Means within a row with no common superscript differ significantly (p < 0.05).

To further verify the effect of insulin on the proliferative capacity of PGCs, we examined the expression levels of cell cycle-related genes (CCND1, ABL1, CCNB1, and CCNF) in PGCs after insulin treatment at different concentrations. The expression of cell cycle-related genes was significantly increased by insulin at 10 μg/mL with less elevation when cells were exposed to higher doses of insulin (p < 0.05) (Figure 3A–D), which was consistent with the results related to cell proliferation assay. These findings suggest that insulin is essential for the culture of PGCs, and insulin mediates PGC proliferation in a typical dose-dependent manner with an optimal concentration of 10 μg/mL.

Figure 3. mRNA levels of CCND1 (A), ABL1 (B), CCNB1 (C), CCNF (D). a,b,c,d,e Means within a row with no common superscript differ significantly (p < 0.05).

3.2. Insulin Can Inhibit the Apoptosis Level of PGCs and Improve the Cell Viability

Studies have shown that insulin can participate in the regulatory process of apoptosis. In the study of insulin affecting the proliferation ability of PGCs, we found that insulin has a greater effect on the cell viability of PGCs. To explore the factors of insulin affecting the viability of PGCs, we examined the level of apoptosis during the culture of PGCs with different concentrations of insulin. The results showed the following (Figure 4A–E): BCL-2 expression was significantly upregulated (p < 0.05); C-myc, Bax, caspase3, and caspase9 expression was significantly downregulated (p < 0.05) after the addition of insulin. It is well known that BCL-2 and C-myc, Bax, caspase3, caspase9 are marker genes for apoptosis levels, and significant apoptosis occurs in cells with downregulation of BCL-2 levels and upregulation of C-myc, Bax, caspase3, caspase9 levels. In order to further clarify the effect of insulin on the apoptosis level of PGCs, we performed flow cytometry analysis via PI. The results showed (Figure 4F,G) that, consistent with the quantitative results, the apoptosis level of PGCs is significantly inhibited via the addition of insulin (p < 0.05). Thus, our results suggest that the addition of insulin reduces the apoptosis of PGCs.

Figure 4. Insulin reduces cell apoptosis in PGCs. (AE) mRNA levels of apoptosis-related genes, BAX (A), BCL2 (B), CASP3 (C), CASP9 (D), C-myc (E). (F,G) Apoptosis rate (F) and flow cytometric analysis (G) of PGCs under insulin treatment. a,b,c,d Means within a row with no common superscript differ significantly (p < 0.05).

3.3. Insulin Can Inhibit the Ferroptosis Level of PGCs and Improve Cell Viability

Ferroptosis is a specific form of cell death that has a significant effect on cell viability. To investigate the effect of ferroptosis levels in PGCs cultured with different concentrations of insulin, we used qRT-PCR to detect the expression of ferroptosis-related genes (GPX4, SLC7A11, and NOX4). The results showed the following (Figure 5A–C): the expression of GPX4 and SLC7A11, marker genes as negative regulators of cellular ferroptosis, showed a trend of upregulation (10 μg/mL) and then downregulation with the increase in insulin addition level during the culture of PGCs, while NOX4, a marker gene for positive regulation, showed the exact opposite trend (p < 0.05). These results tentatively suggest that insulin has the ability to inhibit the level of ferroptosis in PGCs.

Figure 5. Insulin reduces ferroptosis in PGCs. (AC) mRNA levels of ferroptosis-related genes GPX4 (A), NOX4 (B), and SLC7A11 (C). (D) Iron content in PGCs. a,b,c,d,e Means within a row with no common superscript differ significantly (p < 0.05).

To further explore the effect of insulin on the ferroptosis level of PGCs, the ferrous ion content in PGCs was examined in this experiment, and the results showed the following (Figure 5D): Similar to the results of the ferroptosis marker gene, with the increase in insulin addition level, the ferrous ion content in PGCs showed a trend of first decreasing and then upregulating (p < 0.05), and the insulin addition concentration of 10 μg/mL, the ferrous ion content was the lowest, and the intracellular ferrous ion content showed a positive correlation trend with the level of cellular ferroptosis. Therefore, our results suggest that insulin can inhibit the level of ferroptosis in PGCs to improve cell viability.

We also examined the redox levels and the degree of cellular damage in PGCs, and the results showed the following (Figure 6A–D): with the increase in insulin addition level, the total GSH level in PGCs did not change significantly, the oxidized GSSG level showed a trend of first decreasing and then upregulating, the reduced GSH level showed a trend of first upregulating and then decreasing (p < 0.05), and MDA showed a trend of first decreasing and then upregulating trend. At the insulin concentration of 10 μg/mL, PGCs showed the highest reduced GSH, the lowest oxidized GSSG, and the lowest MDA level, while the cellular oxidation level and the degree of cellular damage showed a positive correlation with cellular ferroptosis. In conclusion, insulin was able to inhibit the ferroptosis level of PGCs to improve cell viability.

Figure 6. Insulin reduces the redox levels and the degree of cellular damage in PGCs. (A) Total glutathione in PGCs. (B) Oxidative GSSG in PGCs. (C) GSH in total glutathione in PGCs. (D) MDA level in PGCs. a,b,c,d,e Means within a row with no common superscript differ significantly (p < 0.05).

3.4. Insulin Can Affect Cell Viability of PGCs via PI3K-Akt-mTOR Signaling Pathway

It is well known that PI3K-Akt-mTOR signaling is an important signaling pathway that regulates cell viability. So, does insulin regulate cell viability through this signaling pathway? To prove this hypothesis, we detected the expression of PI3K-Akt-mTOR signaling pathway-related proteins via Western Blot, and the results showed the following (Figure 7A–C): p-PI3K/PI3K protein expression increased after insulin addition and protein expression was upregulated with increasing concentration; p-Akt/Akt protein expression was first upregulated and then downregulated, and 10 μg/mL was the highest (p < 0.05). The results of the qRT-PCR assay showed (Figure 7D–F) that the expression levels of PI3K, Akt, and mTOR genes were significantly increased after the addition of insulin, and the highest gene expression levels were observed at 10 μg/mL insulin (p < 0.05). These results show that insulin activates the PI3K-Akt-mTOR signaling pathway and that insulin concentration determines the pathway activation capacity.

Figure 7. Insulin activates PI3K/AKT/mTOR pathway. (AC) Western blot and quantification of p-PI3K/PI3K (A,B) and p-Akt/Akt (A,C). (DF) mRNA levels of PI3K, AKT1, and MTOR. a,b,c,d,e,f Means within a row with no common superscript differ significantly (p < 0.05).

4. Discussion

Insulin can bind to insulin receptors on cell membranes to regulate various metabolic pathways in cells, increase the synthesis of fatty acids and glucose, and play an important role in cell growth. In vitro studies have shown that insulin has a significant mitogenic effect on cell proliferation [28,29]. Jemima et al. found that PGCs do not proliferate if insulin is removed from B-27 supplementation [30]. The addition of insulin to the culture medium of PGCs better maintains survival and promotes an increase in the number of PGC colonies [31]. In this present study, we found that with the removal of insulin from B-27, PGCs significantly did not proliferate, and the addition of insulin significantly promoted the proliferation of PGCs and increased the expression of cell cycle genes during all phases of mitosis, in agreement with previous studies. In addition, it was shown that insulin promotes cardiomyocyte proliferation and survival via the activation of PI3K/Akt [32,33,34,35]. Phosphorylation levels of the AKT signaling pathway and its downstream proteins may play a key role in maintaining the undifferentiated state of stem cells and regulating stem cell self-renewal and proliferation [36]. mTOR is one of the downstream targets of the PI3K/Akt signaling pathway. It has been shown that mTOR inhibits excessive autophagy and stimulates cell growth, proliferation, and survival as well as metabolism via the upregulation of protein and lipid synthesis [37,38]. We confirmed that insulin addition positively affected the PI3K-Akt-mTOR signaling pathway and promoted the proliferation of PGCs, and the proliferation efficiency of PGCs showed a positive correlation trend with the expression of genes and proteins related to this signaling pathway, which is consistent with the above study. This study elucidated the effects of insulin on PGCs from different concentrations and found that high concentrations of insulin inhibited the proliferation efficiency of PGCs, complementing the theoretical basis for the study of insulin additive doses in PGCs in vitro culture.

Insulin has been shown to protect hepatocytes from saturated fatty acid-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity [39]. Cells die if Bax homodimers predominate, while they survive when Bcl-2 and Bax heterodimers predominate [40]. The overexpression of C-myc is accompanied by apoptosis [41]. Caspase3 and caspase9 are key enzymes in the apoptotic process and play a critical role in apoptosis [42,43]. We found that the addition of insulin inhibited the expression of pro-apoptotic genes Bax, Caspase-3, Caspase-9, and C-myc and promoted the expression of apoptosis-suppressing gene Bcl-2 in PGCs, while the inhibition of apoptosis in PGCs via insulin was confirmed using flow cytometry, which was consistent with the previous results. In addition, it was shown that the inhibition of the PI3K-AKT-mTOR signaling pathway inhibits insulin release and promotes apoptosis [44]. Akt can deliver anti-apoptotic or survival signals by stimulating antioxidant response element activity and subsequent antioxidant enzyme expression and by inducing the upregulation of heme oxygenase expression via the activation of transcription factor e2-related factor 2 [45,46]. We found that the addition of insulin promoted the expression of PI3K-AKT-mTOR signaling pathway-related genes and proteins, confirming the important role of the PI3K-AKT-mTOR signaling pathway on the apoptosis of PGCs.

In addition, it was shown that insulin protects cardiomyocytes from ferroptosis by activating the PI3K/Akt pathway, reducing reactive oxygen species, and maintaining mitochondrial transmembrane potential [47]. The expression of GPX4 and SLC7A11 is reduced when ferroptosis occurs in cells, while NOX4 expression is upregulated [48,49], which is consistent with our study. Meanwhile, it was shown that MaR1 inhibited ferroptosis in mouse hepatocytes and reduced the levels of malondialdehyde (MDA), reduced glutathione (GSH), GSH/oxidized glutathione (GSSG), and iron content [50]. We found that the addition of appropriate insulin reduced intracellular levels of ferric ions, oxidized GSSG, reduced GSH and MDA, and protected PGCs from ferroptosis, in agreement with previous results [50]. In addition, hyperinsulinemia can upregulate hepatic transferrin receptor 1 (TFR1) via PI3K/AKT/mTOR/IRP2 pathway, causing iron overload damage in rat liver, resulting in iron death and reduced cell viability [51], and we found that whereas high insulin concentration leads to ferroptosis in PGCs, high insulin concentration also activates this signaling pathway, validating the results of previous experiments. Overall, we found that insulin can affect ferroptosis levels in PGCs via the PI3K-Akt-mTOR signaling pathway.

5. Conclusions

Collectively, insulin was essential for the in vitro culture of PGCs. The proliferation ability and signaling pathway activation of PGCs were the strongest as well as the least affected by apoptosis and iron death when insulin was added at a concentration of 10 μg/mL. This study provides a valuable reference for the development of a stable and effective in vitro culture medium for PGCs.

References

  1. Bettegowda, A.; Yao, J.; Sen, A.; Li, Q.; Lee, K.B.; Kobayashi, Y.; Patel, O.V.; Coussens, P.M.; Ireland, J.J.; Smith, G.W. JY-1, an oocyte-specific gene, regulates granulosa cell function and early embryonic development in cattle. Proc. Natl. Acad. Sci. USA 2007, 104, 17602–17607. [Google Scholar] [CrossRef] [PubMed]
  2. Heyn, P.; Kircher, M.; Dahl, A.; Kelso, J.; Tomancak, P.; Kalinka, A.T.; Neugebauer, K.M. The earliest transcribed zygotic genes are short, newly evolved, and different across species. Cell Rep. 2014, 6, 285–292. [Google Scholar] [CrossRef]
  3. Petitte, J.N.; Liu, G.; Yang, Z. Avian pluripotent stem cells. Mech. Dev. 2004, 121, 1159–1168. [Google Scholar] [CrossRef]
  4. Ballantyne, M.; Woodcock, M.; Doddamani, D.; Hu, T.; Taylor, L.; Hawken, R.J.; McGrew, M.J. Direct allele introgression into pure chicken breeds using Sire Dam Surrogate (SDS) mating. Nat. Commun. 2021, 12, 659. [Google Scholar] [CrossRef]
  5. Naito, M.; Harumi, T.; Kuwana, T. Long-term culture of chicken primordial germ cells isolated from embryonic blood and production of germline chimaeric chickens. Anim. Reprod. Sci. 2015, 153, 50–61. [Google Scholar] [CrossRef]
  6. Ono, T.; Yokoi, R.; Maeda, S.; Nishida, T.; Aoyama, H. Settlement of Quail Primordial Germ Cells in Chicken Gonads. Anim. Sci. Technol. 1998, 69, 546–555. [Google Scholar]
  7. Glover, J.D.; McGrew, M.J. Primordial Germ Cell Technologies for Avian Germplasm Cryopreservation and Investigating Germ Cell Development. J. Poult. Sci. 2012, 49, 155–162. [Google Scholar] [CrossRef]
  8. Lemoine, M.; Grasseau, I.; Brillard, J.P.; Blesbois, E. A reappraisal of the factors involved in in vitro initiation of the acrosome reaction in chicken spermatozoa. Reproduction 2008, 136, 391–399. [Google Scholar] [CrossRef]
  9. Park, T.S.; Lee, H.J.; Kim, K.H.; Kim, J.S.; Han, J.Y. Targeted gene knockout in chickens mediated by TALENs. Proc. Natl. Acad. Sci. USA 2014, 111, 12716–12721. [Google Scholar] [CrossRef]
  10. Petitte, J.N. Avian germplasm preservation: Embryonic stem cells or primordial germ cells? Poult. Sci. 2006, 85, 237–242. [Google Scholar] [CrossRef]
  11. Schusser, B.; Yi, H.; Collarini, E.J.; Izquierdo, S.M.; Harriman, W.D.; Etches, R.J.; Leighton, P.A. Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire. PLoS ONE 2013, 8, e80108. [Google Scholar] [CrossRef] [PubMed]
  12. van de Lavoir, M.C.; Diamond, J.H.; Leighton, P.A.; Mather-Love, C.; Heyer, B.S.; Bradshaw, R.; Kerchner, A.; Hooi, L.T.; Gessaro, T.M.; Swanberg, S.E.; et al. Germline transmission of genetically modified primordial germ cells. Nature 2006, 441, 766–769. [Google Scholar] [CrossRef]
  13. Dolci, S.; Pesce, M.; De Felici, M. Combined action of stem cell factor, leukemia inhibitory factor, and cAMP on in vitro proliferation of mouse primordial germ cells. Mol. Reprod. Dev. 1993, 35, 134–139. [Google Scholar] [CrossRef] [PubMed]
  14. Dolci, S.; Williams, D.E.; Ernst, M.K.; Resnick, J.L.; Brannan, C.I.; Lock, L.F.; Lyman, S.D.; Boswell, H.S.; Donovan, P.J. Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature 1991, 352, 809–811. [Google Scholar] [CrossRef]
  15. Farini, D.; Scaldaferri, M.L.; Iona, S.; La Sala, G.; De Felici, M. Growth factors sustain primordial germ cell survival, proliferation and entering into meiosis in the absence of somatic cells. Dev. Biol. 2005, 285, 49–56. [Google Scholar] [CrossRef]
  16. Matsui, Y.; Toksoz, D.; Nishikawa, S.; Nishikawa, S.; Williams, D.; Zsebo, K.; Hogan, B.L. Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature 1991, 353, 750–752. [Google Scholar] [CrossRef]
  17. Pesce, M.; Farrace, M.G.; Piacentini, M.; Dolci, S.; De Felici, M. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 1993, 118, 1089–1094. [Google Scholar] [CrossRef]
  18. Godin, I.; Deed, R.; Cooke, J.; Zsebo, K.; Dexter, M.; Wylie, C.C. Effects of the steel gene product on mouse primordial germ cells in culture. Nature 1991, 352, 807–809. [Google Scholar] [CrossRef]
  19. Koshimizu, U.; Taga, T.; Watanabe, M.; Saito, M.; Shirayoshi, Y.; Kishimoto, T.; Nakatsuji, N. Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells. Development 1996, 122, 1235–1242. [Google Scholar] [CrossRef]
  20. Matsui, Y.; Zsebo, K.; Hogan, B.L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992, 70, 841–847. [Google Scholar] [CrossRef]
  21. Resnick, J.L.; Bixler, L.S.; Cheng, L.; Donovan, P.J. Long-term proliferation of mouse primordial germ cells in culture. Nature 1992, 359, 550–551. [Google Scholar] [CrossRef]
  22. Sun, R.; Sun, Y.C.; Ge, W.; Tan, H.; Cheng, S.F.; Yin, S.; Sun, X.F.; Li, L.; Dyce, P.; Li, J.; et al. The crucial role of Activin A on the formation of primordial germ cell-like cells from skin-derived stem cells in vitro. Cell Cycle 2015, 14, 3016–3029. [Google Scholar] [CrossRef]
  23. Zhang, X.; Sheng, X.; Miao, T.; Yao, K.; Yao, D. Effect of insulin on thyroid cell proliferation, tumor cell migration, and potentially related mechanisms. Endocr. Res. 2019, 44, 55–70. [Google Scholar] [CrossRef]
  24. Hansen, B.F.; Kurtzhals, P.; Jensen, A.B.; Dejgaard, A.; Russell-Jones, D. Insulin X10 revisited: A super-mitogenic insulin analogue. Diabetologia 2011, 54, 2226–2231. [Google Scholar] [CrossRef]
  25. Nath, A.; Hakim, B.A.; Rajender, S.; Singh, K.; Sachdev, M.; Konwar, R. Effect of insulin supplementation on in vitro maturation of pre-antral follicles from adult and pre-pubertal mice. In Vitro Cell. Dev. Biol. Anim. 2016, 52, 512–521. [Google Scholar] [CrossRef] [PubMed]
  26. Godoy-Parejo, C.; Deng, C.; Liu, W.; Chen, G. Insulin Stimulates PI3K/AKT and Cell Adhesion to Promote the Survival of Individualized Human Embryonic Stem Cells. Stem Cells 2019, 37, 1030–1041. [Google Scholar] [CrossRef] [PubMed]
  27. Pfeifle, B.; Ditschuneit, H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981, 20, 155–158. [Google Scholar] [CrossRef]
  28. Kurtzhals, P.; Schaffer, L.; Sorensen, A.; Kristensen, C.; Jonassen, I.; Schmid, C.; Trub, T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000, 49, 999–1005. [Google Scholar] [CrossRef]
  29. Tennagels, N.; Werner, U. The metabolic and mitogenic properties of basal insulin analogues. Arch. Physiol. Biochem. 2013, 119, 1–14. [Google Scholar] [CrossRef] [PubMed]
  30. Whyte, J.; Glover, J.D.; Woodcock, M.; Brzeszczynska, J.; Taylor, L.; Sherman, A.; Kaiser, P.; McGrew, M.J. FGF, Insulin, and SMAD Signaling Cooperate for Avian Primordial Germ Cell Self-Renewal. Stem Cell Rep. 2015, 5, 1171–1182. [Google Scholar] [CrossRef] [PubMed]
  31. Xin-Yan, T.; Wei-Dong, Z.; Yu-Ling, M.; Hong-Yun, L.; Cai-Qiao, Z. Isolation, culture and characterization of chicken primordial germ cells. Chin. J. Agric. Biotechnol. 2007, 3, 183–188. [Google Scholar] [CrossRef]
  32. Aikawa, R.; Nawano, M.; Gu, Y.; Katagiri, H.; Asano, T.; Zhu, W.; Nagai, R.; Komuro, I. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000, 102, 2873–2879. [Google Scholar] [CrossRef]
  33. Harney, J.A.; Rodgers, R.L. Insulin-like stimulation of cardiac fuel metabolism by physiological levels of glucagon: Involvement of PI3K but not cAMP. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E155–E161. [Google Scholar] [CrossRef]
  34. Si, R.; Tao, L.; Zhang, H.F.; Yu, Q.J.; Zhang, R.; Lv, A.L.; Zhou, N.; Cao, F.; Guo, W.Y.; Ren, J.; et al. Survivin: A novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J. Mol. Cell Cardiol. 2011, 50, 16–24. [Google Scholar] [CrossRef]
  35. Wang, M.; Sun, G.B.; Sun, X.; Wang, H.W.; Meng, X.B.; Qin, M.; Sun, J.; Luo, Y.; Sun, X.B. Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway. Toxicol. Lett. 2013, 216, 100–107. [Google Scholar] [CrossRef] [PubMed]
  36. Karami Fath, M.; Ebrahimi, M.; Nourbakhsh, E.; Hazara, A.Z.; Mirzaei, A.; Shafieyari, S.; Salehi, A.; Hoseinzadeh, M.; Payandeh, Z.; Barati, G. PI3K/Akt/mTOR signaling pathway in cancer stem cells. Pathol. Res. Pract. 2022, 237, 154010. [Google Scholar] [CrossRef]
  37. Hu, X.; Xu, C.; Zhou, X.; Cui, B.; Lu, Z.; Jiang, H. PI3K/Akt signaling pathway involved in cardioprotection of preconditioning with high mobility group box 1 protein during myocardial ischemia and reperfusion. Int. J. Cardiol. 2011, 150, 222–223. [Google Scholar] [CrossRef] [PubMed]
  38. Liao, L.Z.; Chen, Y.L.; Lu, L.H.; Zhao, Y.H.; Guo, H.L.; Wu, W.K. Polysaccharide from Fuzi likely protects against starvation-induced cytotoxicity in H9c2 cells by increasing autophagy through activation of the AMPK/mTOR pathway. Am. J. Chin. Med. 2013, 41, 353–367. [Google Scholar] [CrossRef] [PubMed]
  39. Pagliassotti, M.J.; Wei, Y.; Wang, D. Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. Endocrinology 2007, 148, 3338–3345. [Google Scholar] [CrossRef]
  40. Nagoshi, T.; Matsui, T.; Aoyama, T.; Leri, A.; Anversa, P.; Li, L.; Ogawa, W.; del Monte, F.; Gwathmey, J.K.; Grazette, L.; et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 2005, 115, 2128–2138. [Google Scholar] [CrossRef]
  41. Thompson, E.B. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol. 1998, 60, 575–600. [Google Scholar] [CrossRef] [PubMed]
  42. Brentnall, M.; Rodriguez-Menocal, L.; De Guevara, R.L.; Cepero, E.; Boise, L.H. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013, 14, 32. [Google Scholar] [CrossRef] [PubMed]
  43. Paasch, U.; Grunewald, S.; Fitzl, G.; Glander, H.J. Deterioration of plasma membrane is associated with activated caspases in human spermatozoa. J. Androl. 2003, 24, 246–252. [Google Scholar] [CrossRef] [PubMed]
  44. Tong, L.; Li, W.; Zhang, Y.; Zhou, F.; Zhao, Y.; Zhao, L.; Liu, J.; Song, Z.; Yu, M.; Zhou, C.; et al. Tacrolimus inhibits insulin release and promotes apoptosis of Min6 cells through the inhibition of the PI3K/Akt/mTOR pathway. Mol. Med. Rep. 2021, 24, 658. [Google Scholar] [CrossRef] [PubMed]
  45. Tan, Y.; Ichikawa, T.; Li, J.; Si, Q.; Yang, H.; Chen, X.; Goldblatt, C.S.; Meyer, C.J.; Li, X.; Cai, L.; et al. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011, 60, 625–633. [Google Scholar] [CrossRef]
  46. Yaoita, H.; Ogawa, K.; Maehara, K.; Maruyama, Y. Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction. Cardiovasc. Res. 2000, 45, 630–641. [Google Scholar] [CrossRef]
  47. Teshima, Y.; Takahashi, N.; Thuc, L.C.; Nishio, S.; Nagano-Torigoe, Y.; Miyazaki, H.; Ezaki, K.; Yufu, K.; Hara, M.; Nakagawa, M.; et al. High-glucose condition reduces cardioprotective effects of insulin against mechanical stress-induced cell injury. Life Sci. 2010, 87, 154–161. [Google Scholar] [CrossRef]
  48. Li, X.Y.; Leung, P.S. Erastin-induced ferroptosis is a regulator for the growth and function of human pancreatic islet-like cell clusters. Cell Regen. 2020, 9, 16. [Google Scholar] [CrossRef]
  49. Wu, H.; Wang, Y.; Tong, L.; Yan, H.; Sun, Z. Global Research Trends of Ferroptosis: A Rapidly Evolving Field with Enormous Potential. Front. Cell Dev. Biol. 2021, 9, 646311. [Google Scholar] [CrossRef]
  50. Yang, W.; Wang, Y.; Zhang, C.; Huang, Y.; Yu, J.; Shi, L.; Zhang, P.; Yin, Y.; Li, R.; Tao, K. Maresin1 Protect against Ferroptosis-Induced Liver Injury through ROS Inhibition and Nrf2/HO-1/GPX4 Activation. Front. Pharmacol. 2022, 13, 865689. [Google Scholar] [CrossRef] [PubMed]
  51. Jiang, X.; Wang, H.; Shi, W.; Shen, Z.; Shen, H.; Li, M. Hyperinsulinemia induces hepatic iron overload by increasing liver TFR1 via the PI3K/IRP2 pathway. J. Mol. Endocrinol. 2014, 53, 381–392. [Google Scholar] [CrossRef] [PubMed]
Related Suggestion
Heterozygous Knockout of ARID4B Using CRISPR/Cas9 Attenuates Some Aggressive Phenotypes in a Breast Cancer Cell Line
Knowledge
Breast cancer is one of the leading causes of death in women around the world. Over time, many genes and mutations that are associated with the development of this disease have been identified. However, the specific role of many genes has not yet been fully elucidated. Higher ARID4B expression has been identified as a risk factor for diverse cancer types. Silencing experiments also showed that ARID4B is associated with developing cancer-associated characteristics. However, no transcriptomic studies have shown the overall cellular effect of loss of function in breast cancer in humans. This study addresses the impact of loss-of-function mutations in breast cancer MCF-7 cells. Using the CRISPR/Cas9 system, we generated mutations that caused heterozygous truncated proteins, isolating three monoclonal lines carrying insertions and deletions in ARID4B. We observed reduced proliferation and migration in in vitro experiments. In addition, from RNA-seq assays, a differential expression analysis shows known and novel deregulated cancer-associate pathways in mutated cells supporting the impact of ARID4B. For example, we found the AKT-PI3K pathway to be altered at the transcript level but through different genes than those reported for ARID4B. Our transcriptomic results also suggest new insights into the role of ARID4B in aggressiveness by the epithelial-to-mesenchymal transition and TGF-β pathways and in metabolism through cholesterol and mevalonate pathways. We also performed exome sequencing to show that no off-target effects were apparent. In conclusion, the ARID4B gene is associated with some aggressive phenotypes in breast cancer cells.
592
0
Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis
Knowledge
For the first time, based on the expression analysis of a wide range of pro- and anti-fibrotic, pro- and anti-inflammatory, and pro- and anti-apoptotic genes, key markers of endoplasmic reticulum stress (ER-stress), molecular mechanisms for the regulation of fibrosis, and accompanying negative processes caused by thioacetamide (TAA) injections and subsequent injections of selenium-containing nanoparticles and sorafenib have been proposed. We found that selenium nanoparticles of two types (doped with and without sorafenib) led to a significant decrease in almost all pro-fibrotic and pro-inflammatory genes. Sorafenib injections also reduced mRNA expression of pro-fibrotic and pro-inflammatory genes but less effectively than both types of nanoparticles. In addition, it was shown for the first time that TAA can be an inducer of ER-stress, most likely activating the IRE1α and PERK signaling pathways of the UPR, an inducer of apoptosis and pyroptosis. Sorafenib, despite a pronounced anti-apoptotic effect, still did not reduce the expression of caspase-3 and 12 or mitogen-activated kinase JNK1 to control values, which increases the risk of persistent apoptosis in liver cells. After injections of selenium-containing nanoparticles, the negative effects caused by TAA were leveled, causing an adaptive UPR signaling response through activation of the PERK signaling pathway. The advantages of selenium-containing nanoparticles over sorafenib, established in this work, once again emphasize the unique properties of this microelement and serve as an important factor for the further introduction of drugs based on it into clinical practice.
94
0
The Regulatory Effects of JAK2/STAT3 on Spermatogenesis and the Redox Keap1/Nrf2 Axis in an Animal Model of Testicular Ischemia Reperfusion Injury
Knowledge
The male reproductive system requires the pleiotropic activity of JAK/STAT to maintain its function, especially spermatogenesis. The study aims to investigate the effect of JAK2 signaling on the expression of the Keap1/Nrf2 axis, spermatogenesis, and the Sertoli cells (Sc) junctions in an animal model of testicular ischemia reperfusion injury (tIRI). Testes subjected to tIRI exhibited increased JAK2/STAT3 activity associated with spermatogenic arrest and reduced expression of the Sc junctions. In addition, there was an increased protein expression of Keap1 and decreased Nrf2., which was coupled with the downregulation of gene expression of antioxidant enzymes. Reduced SOD and CAT activities were accompanied by increased lipid peroxidation and protein carbonylation during tIRI. Increased caspase 9 activity and Bax/Bcl2 ratio indicated initiation of apoptosis. Inhibition of JAK2 activity by AG490 maintained the integrity of spermatogenesis and SC junctions, normalized the expression of the Keap1/Nrf2 axis and its downstream antioxidant enzymes, and prevented germ cell apoptosis. The results further emphasized the regulatory role of JAK2/STAT3 on spermatogenesis, Keap1/Nrf2 signaling, and maintenance of the testicular redox balance to combat testicular dysfunction and male infertility.
131
0
Comments 0
Please to post a comment~
Loading...
Likes
Send-Pen
Favorites
Comment